ENSG

Ensign Group Inc

Add to Watchlist

Advanced Chart

161.700

+1.07(0.666%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

162.760

Open

160.690

VWAP

159.93

Vol

569.22K

Mkt Cap

9.33B

Low

159.580

Amount

91.03M

EV/EBITDA(TTM)

18.31

Total Shares

56.92M

9.00B

EV/OCF(TTM)

19.44

P/S(TTM)

2.04

The Ensign Group, Inc., through its independent operating subsidiaries, offers a range of skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate. The Company's segments include Skilled Services and Standard Bearer. The Skilled Services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment is comprised of select properties owned by it through its captive real estate investment trust (REIT) and leased to skilled nursing and senior living operations, including its own independent subsidiaries and third-party operators. The Company has over 361 healthcare operations, which includes 47 senior living operations, across 17 states. Its subsidiaries, including Standard Bearer Healthcare REIT, Inc., own around 148 real estate assets. Its operations are located in Alabama, Alaska, Arizona, California, Colorado and others.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

1.34B

+14.4%

1.718

+25.09%

1.33B

+17.25%

1.690

+13.45%

1.28B

+17.91%

1.603

+15.34%

Estimates Revision

The market is revising Upward the revenue expectations for The Ensign Group, Inc. (ENSG) for FY2025, with the revenue forecasts being adjusted by 1.77% over the past three months. During the same period, the stock price has changed by 14.22%.

Revenue Estimates for FY2025

Revise Upward

+1.77%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+1.6%

In Past 3 Month

Stock Price

Go Up

+14.22%

In Past 3 Month

6 Analyst Rating

6.78% Upside

Wall Street analysts forecast ENSG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENSG is 172.67 USD with a low forecast of 165.00 USD and a high forecast of 185.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

5 Buy

1 Hold

0 Sell

Strong Buy

6.78% Upside

Current: 161.700

Low

165.00

Averages

172.67

High

185.00

6.78% Upside

Current: 161.700

Low

165.00

Averages

172.67

High

185.00

Stephens

Overweight

maintain

$165 -> $170

2025-07-28

Reason

Stephens

Price Target

$165 -> $170

2025-07-28

maintain

Overweight

Reason

Stephens raised the firm's price target on Ensign Group to $170 from $165 and keeps an Overweight rating on the shares. Despite Ensign contending with uncertainty surrounding the long-term Medicaid reimbursement backdrop for Skilled Nursing Facilities, fundamentals "have not wavered," says the analyst, who raises estimates following the company's Q2 report.

Truist

David MacDonald

Hold

maintain

$155 -> $165

2025-07-28

Reason

Truist

David MacDonald

Price Target

$155 -> $165

2025-07-28

maintain

Hold

Reason

Truist analyst David MacDonald raised the firm's price target on Ensign Group to $165 from $155 and keeps a Hold rating on the shares. The company reported another quarter of upbeat results featuring top and bottom-line beats and raised its FY25 guidance, the analyst tells investors in a research note. Ensign's occupancy and skill mix trends continue to show strength while labor improvement is ongoing and new facilities continue to outperform, the firm added.

Oppenheimer

Outperform

maintain

$168 -> $170

2025-07-25

Reason

Oppenheimer

Price Target

$168 -> $170

2025-07-25

maintain

Outperform

Reason

Oppenheimer raised the firm's price target on Ensign Group to $170 from $168 and keeps an Outperform rating on the shares following quarterly results. The firm notes the company raised FY2025 EPS guidance to $6.34-$6.46 vs. $6.22-$6.38 based on revenues of $4.99-$5.02B vs. $4.89-$4.94B. Overall, with healthcare companies generally struggling, Ensign is building on its strong consistent track-record, with another impressive beat and raise, says Oppenheimer.

Stephens & Co.

Raj Kumar

Buy

Maintains

$155 → $160

2025-02-07

Reason

Stephens & Co.

Raj Kumar

Price Target

$155 → $160

2025-02-07

Maintains

Buy

Reason

Stephens & Co.

Raj Kumar

Buy

Reiterates

$155

2025-02-06

Reason

Stephens & Co.

Raj Kumar

Price Target

$155

2025-02-06

Reiterates

Buy

Reason

Macquarie

Tao Qiu

Buy

Maintains

$165 → $166

2025-02-04

Reason

Macquarie

Tao Qiu

Price Target

$165 → $166

2025-02-04

Maintains

Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Ensign Group Inc (ENSG.O) is 23.77, compared to its 5-year average forward P/E of 20.93. For a more detailed relative valuation and DCF analysis to assess Ensign Group Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Overvalued

5Y Average PE

20.93

Current PE

23.77

Overvalued PE

23.12

Undervalued PE

18.74

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Overvalued

5Y Average EV/EBITDA

15.58

Current EV/EBITDA

17.46

Overvalued EV/EBITDA

17.16

Undervalued EV/EBITDA

14.01

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Overvalued

5Y Average PS

1.54

Current PS

1.73

Overvalued PS

1.71

Undervalued PS

1.36